Relenopride Hydrochloride
Relenopride Hydrochloride is in phase II clinical trials for the treatment of chronic constipation. It is developed by SK biopharmaceuticals.
General Information
Update Date：2015-09-29
- Drug Name：
- Relenopride Hydrochloride
- Research Code：
- YKP-10811
- Trade Name：
- MOA：
- 5-HT agonist
- Indication：
- Chronic constipation
- Status：
- Phase II (Active)
- Company：
- SK Biopharmaceuticals (Originator)
- Sales：
- ATC Code：
Chemical Structure
Update Date：2015-09-29
|
Molecular Weight | 529.43 | ||||||||||||
| Formula | C24H30ClFN4O4●HCl | |||||||||||||
| CAS No. |
1221416-43-8 (Relenopride); 1221416-42-7 (Relenopride Hydrochloride); |
|||||||||||||
| Chemical Name | Benzamide, 4-amino-N-[[1-[(3S)-3-[(aminocarbonyl)oxy]-3-(4-fluorophenyl)propyl]-4-piperidinyl]methyl]-5-chloro-2-methoxy-, hydrochloride (1:1) | |||||||||||||
| Relenopride （Free Acid/Base）Parameters： | ||||||||||||||
|
||||||||||||||
| *：Calculated by ACD/Labs software V11.02. | ||||||||||||||